AMD To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Monday

Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impact

Boston Scientific (BSX) stock fell 6% after the medical device maker cut its Q4 sales and full-year EPS guidance due to ongoing disruptions from an August cyberattack. The company estimated the eight-day cyberattack cost it 300 basis points in sales growth and $0.07 in adjusted EPS. Management expects a slow recovery with 2027 projected as the trough year, though the stock now trades at a relatively low 13x forward earnings multiple.

Abbott Receives FDA Approval For First And Only Device In The U.S. To Treat Leaks After Heart Valve Replacement Without Additional Surgery

Abbott's Role in the Growing Global Leadless Pacemaker Market

Abbott continues to address clinical needs in the leadless pacemaker market with its AVEIR DR system as the industry projects significant growth through 2036.

This M&T Bank Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

Analysts downgraded M&T Bank, Bank of Hawaii, HubSpot, Abbott and Moderna; Bank of Hawaii cut its target, while HubSpot’s rose.

Align Technology Reports Third Quarter 2026 Financial Results

Align Technology, Inc. reported third-quarter 2026 revenue of $1.015 billion and adjusted earnings per share of $2.80, both exceeding analyst expectations.

Align Technology Issues Fourth Quarter 2026 Revenue Guidance

Align Technology, Inc. provided revenue guidance for the fourth quarter of 2026, projecting a range between $1.00 billion and $1.02 billion.